Preview

Oncohematology

Advanced search

Prediction of hemorrhagic complications during treatment of children with malignant diseases

https://doi.org/10.17650/1818-8346-2012-7-1-15-21

Abstract

Achievement of platelet diagnostic threshold less than 28.0 × 109/l and prothrombin activity less than 40 % with system inflammatory response (SIRS) were considered as high risk for spontaneous bleeding complication development within the next day in cancer patients. If platelets count is more than 28.5 × 109/l in a combination to prothrombin activity ≥ 40 % and absence of SIRS, it is possible to say that coagulations changes cannot be the independent cause of bleeding and does not require correction of coagulation parameters.

About the Authors

V. V. Dmitriev
Belarusian Research Center for Pediatric Oncology and Hematology
Russian Federation


I. A. Dunaev
Belarusian Research Center for Pediatric Oncology and Hematology
Russian Federation


References

1. Румянцев А.Г., Масчан А.А., Самочатова Е.В. Сопроводительная терапия и контроль инфекций при гематологических и онкологических заболеваниях. M.: Медпрактика-М, 2006. 504 с.

2. Rickles F.R., Falanga A., Montesinos P. et al. Bleeding and thrombosis in acute leukemia: What does the future of therapy look like? Thromb Res 2007;120(Suppl 2):99–106.

3. Hongo T., Okada S., Ohzeki T. et al. Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS. Japan Association of Childhood Leukemia Study. Pediatr Int 2002;44:293–9.

4. Дмитриев В.В., Дунаев И.А. Селективная коррекция нарушений гемостаза у детей с острым лейкозом и злокачественными новообразованиями. Онкогематол 2009;4:22–6.

5. Gibson B.E., Todd F., Roberts I. et al. Transfusion guidelines for neonates and older children. British Committee for standards in Haematology Transfusion Task Force: Writing group. Br J Haematol 2004;124(4):433–53.

6. Варфоломеева С.Р. , Качанов Д.Ю., Шнейдер М.М. и соавт. Диспансерное наблюдение детей и подростков с онкогематологическими заболеваниями педиатром общей практики. Онкогематол

7. ;1–2:63–7.

8. Румянцев А.Г., Аграненко В.А. Клиническая трансфузиология. М.: ГЭОТАР МЕДИЦИНА, 1988. 575 с.

9. Vigna P.D., Monfandini L., Bonomo G. et al. Coagulation disordes in patients with cancer: nontunneled central venous catheter placement with US guidance – a single institution retrospective analysis. Radiology 2009;253(1):249–52.

10. Hemker H.C., Dieri R.A., Smedt E.D., Beguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb hemost 2006;96:553–61.


Review

For citations:


Dmitriev V.V., Dunaev I.A. Prediction of hemorrhagic complications during treatment of children with malignant diseases. Oncohematology. 2012;7(1):15-21. (In Russ.) https://doi.org/10.17650/1818-8346-2012-7-1-15-21

Views: 9713


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)